SCHEMBL6944331

SCHEMBL6944331

CCCCCCCC/C=C\CCCCCCCCOCC[N+](C)(C)CCOCCCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.46
LPAR2 Q9HBW0 1/20 0.46
LPAR3 Q9UBY5 1/20 0.46
HTT P42858 1/20 0.45
FAAH O00519 2/20 0.44
TRPV1 Q8NER1 1/20 0.44
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCI P41743 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKD1 Q15139 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944334 1.00 LPAR1 (0.46) LPAR1LPAR2LPAR3HTTFAAH
Hydrochloric Acid SCHEMBL2872041 0.98 LPAR1 (0.45) LPAR1LPAR2LPAR3HTTFAAH
Hydrochloric Acid SCHEMBL2872033 0.98 LPAR1 (0.45) LPAR1LPAR2LPAR3HTTFAAH
Hydrochloric Acid SCHEMBL30621326 0.95 HTT (0.50) HTT
SCHEMBL9129466 0.89 PRKD3 (0.56) LPAR1LPAR2LPAR3PRKD3PRKCG
SCHEMBL9129474 0.89 PRKD3 (0.56) LPAR1LPAR2LPAR3PRKD3PRKCG
Hydrochloric Acid SCHEMBL2870007 0.87 LPAR1 (0.45) LPAR1LPAR2LPAR3FAAHTRPV1
Hydrochloric Acid SCHEMBL2870004 0.87 LPAR1 (0.45) LPAR1LPAR2LPAR3FAAHTRPV1
SCHEMBL3371265 0.87 RECQL (0.41) LPAR1LPAR3TRPV1PRKD3PRKCG
SCHEMBL6949117 0.87 RECQL (0.41) LPAR1LPAR3TRPV1PRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946699-B1 DRYER-ACTIVATED FABRIC CONDITIONING AND ANTISTATIC COMPOSITIONS WITH IMPROVED PERFUME LONGEVITY PROCTER & GAMBLE (US) 2003-10-15 EP claimed
EP-0906395-B1 POLYAMINES HAVING FABRIC APPEARANCE ENHANCEMENT BENEFITS PROCTER & GAMBLE (US) 2002-08-14 EP claimed
EP-0704522-B1 Dryer-activated fabric conditioning compositions containing unsaturated fatty acid PROCTER & GAMBLE (US) 2001-11-28 EP claimed
EP-0843717-B1 DRYER-ACTIVATED FABRIC CONDITIONING AND ANTISTATIC COMPOSITIONS WITH IMPROVED PERFUME LONGEVITY PROCTER & GAMBLE (US) 2000-03-22 EP claimed
EP-0712441-B1 DRYER-ACTIVATED FABRIC CONDITIONING COMPOSITIONS CONTAINING ETHOXYLATED/PROPOXYLATED SUGAR DERIVATIVES PROCTER & GAMBLE (US) 1999-10-20 EP claimed
US-9920028-B2 Cationic lipid KYOWA HAKKO KIRIN CO., LTD. (JP) 2018-03-20 US disclosed
EP-3275448-A1 NUCLEIC ACID-CONTAINING LIPID NANOPARTICLES Kyowa Hakko Kirin Co., Ltd. (JP) 2018-01-31 EP disclosed
US-9845306-B2 Cationic lipid KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-12-19 US disclosed
US-20170349532-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-12-07 US disclosed
US-20160304487-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO LTD (JP) 2016-10-20 US disclosed
WO-2016153012-A1 NUCLEIC ACID-CONTAINING LIPID NANOPARTICLES 協和発酵キリン株式会社 2016-09-29 WO disclosed
US-9408914-B2 Cationic lipid KYOWA HAKKO KIRIN CO., LTD. (JP) 2016-08-09 US disclosed
US-20150343062-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO LTD (JP) 2015-12-03 US disclosed
US-20140045913-A1 LIPID NANO PARTICLES COMPRISING COMBINATION OF CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-02-13 US disclosed
US-20130280305-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-10-24 US disclosed
US-20130108685-A1 CATIONIC LIPID KYOWA KIRIN CO., LTD. (JP) 2013-05-02 US disclosed
WO-2011136368-A1 CATIONIC LIPID 協和発酵キリン株式会社 (JP) 2011-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304487-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885
US-20140045913-A1 LIPID NANO PARTICLES COMPRISING COMBINATION OF CATIONIC LIPID LPAR3, APOL1, PLIN3 LPAR1 4/4885LPAR2 9/4885LPAR3 1/4885
US-20170349532-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885
US-20130108685-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885
US-20130280305-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885
US-20150343062-A1 CATIONIC LIPID ACOX3, LPAR3, ELOVL3 LPAR1 8/4885LPAR2 16/4885LPAR3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.